This company has been marked as potentially delisted and may not be actively trading. Medicines (MDCO) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock MDCO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Valneva’s Chikungunya Vaccine Restriction Lifted by EMAJuly 11 at 2:45 PM | tipranks.comBeOne Medicines (ONC) Gains EU Approval for Tevimbra in Cancer TherapyJuly 10, 2025 | gurufocus.comKingworld Medicines Clarifies 2025 Share Award Scheme DetailsJuly 10, 2025 | tipranks.comBeOne Medicines (ONC) Gains EU Approval for TEVIMBRA in Nasopharyngeal Carcinoma | ONC Stock NewsJuly 10, 2025 | gurufocus.comRevolution Medicines: Strategic Growth and Financial Stability Drive Buy RatingJuly 10, 2025 | tipranks.comBiocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug DevelopmentJuly 9, 2025 | financialpost.comFBiocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug DevelopmentJuly 9, 2025 | financialpost.comFTop Executives at Blueprint Medicines Make Significant Stock Sales!July 8, 2025 | tipranks.comGSK's Specialty Medicines Surge - Still Looks Undervalued In 2025July 7, 2025 | seekingalpha.comRevolution Medicines' SWOT analysis: stock's potential in cancer therapiesJuly 6, 2025 | investing.comKingworld Medicines Announces Share Grant Under 2025 SchemeJuly 4, 2025 | tipranks.comEverest Medicines Unveils Breakthroughs in AI+mRNA Platform, Reinforces Global Leadership in ...July 4, 2025 | gurufocus.comBuy Rating for BeOne Medicines: Promising Developments and Strategic PositioningJuly 4, 2025 | tipranks.comOppenheimer Reaffirms Outperform on Revolution Medicines, Cites PDAC and NSCLC Trial ProgressJuly 3, 2025 | finance.yahoo.comOppenheimer Reaffirms Outperform on Revolution Medicines, Cites PDAC and NSCLC Trial ProgressJuly 2, 2025 | insidermonkey.com3D Medicines, Inc. Enhances Operational Stability Through Strategic CooperationJuly 1, 2025 | tipranks.comStrategic Collaboration and Promising Trial Results Drive Buy Rating for Revolution MedicinesJuly 1, 2025 | tipranks.comRevolution Medicines and Summit Therapeutics in-pact for cancer treatmentsJune 30, 2025 | seekingalpha.comRevolution Medicines Holds Annual Stockholders MeetingJune 27, 2025 | tipranks.comBeOne Medicines (ONC) Maintains Overweight Rating Amid Price Target Increase | ONC Stock NewsJune 27, 2025 | gurufocus.comEverest Medicines Ltd. AGM Approves Key Resolutions and Executive AwardsJune 27, 2025 | tipranks.comJPMorgan Analyst Boosts Price Target for BeOne Medicines (ONC) | ONC Stock NewsJune 27, 2025 | gurufocus.comOmeros Submits Narsoplimab Marketing Authorization Application to the European Medicines Agency ...June 27, 2025 | gurufocus.comTYK Medicines, Inc Announces Board Composition and RolesJune 26, 2025 | tipranks.comTYK Medicines, Inc. Successfully Concludes 2024 AGM with Key AppointmentsJune 26, 2025 | tipranks.com7.7 Million Doses Of Illegal Medicines Seized In UK June 26, 2025 | rttnews.comBeOne Medicines Showcases Groundbreaking Oncology Pipeline at R&D DayJune 26, 2025 | financialpost.comFRevolution Medicines To Advance Lead Cancer Drug With $2 Billion In FundsJune 24, 2025 | benzinga.comStrategic Partnership with Royalty Pharma Enhances Revolution Medicines’ Financial Flexibility and Growth PotentialJune 24, 2025 | tipranks.comRoyalty Pharma Announces $2 Billion Funding Arrangement with Revolution Medicines for Daraxonrasib DevelopmentJune 24, 2025 | quiverquant.comQRevolution Medicines (RVMD) Earns FDA Breakthrough Status for Cancer Drug | RVMD Stock NewsJune 23, 2025 | gurufocus.comGSK’s Linerixibat for PBC Pruritus Under EMA ReviewJune 23, 2025 | tipranks.comGSK’s Linerixibat for PBC Pruritus Gains EMA Review AcceptanceJune 23, 2025 | tipranks.comRevolution Medicines: Positioning Itself To Capture One Of The Largest Cancer Targets In HistoryJune 19, 2025 | seekingalpha.comRevolution Medicines COO Horn sells $139k in stockJune 18, 2025 | investing.comBeOne Medicines: Brukinsa Momentum And Pipeline Catalysts Justify Its PremiumJune 16, 2025 | seekingalpha.comBeOne Medicines Ltd. Announces Share Option GrantsJune 13, 2025 | tipranks.comGSK’s RSV Vaccine Expansion Under EMA ReviewJune 13, 2025 | tipranks.comEverest Medicines Expands Shareholder Base with Strategic Share DisposalJune 12, 2025 | tipranks.comBeOne Medicines to Host Investor R&D Day Webcast on June 26, 2025 | ONC Stock NewsJune 11, 2025 | gurufocus.comEverest Medicines Presents Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of Novel BTK Inhibitor EVER001 at the 62nd Congress of the European Renal AssociationJune 9, 2025 | investing.comEverest Medicines Presents Positive Results from Phase 1b/2a Clinical Trial of EVER001 for ...June 9, 2025 | gurufocus.comTYK Medicines, Inc. Seeks Approval for H Share Full CirculationJune 6, 2025 | tipranks.comBlueprint Medicines’ CSO Makes a Significant Stock Sale!June 5, 2025 | tipranks.com3D Medicines Inc. Announces Annual General Meeting to Discuss Key ResolutionsJune 5, 2025 | tipranks.com3D Medicines Inc. Announces Board Changes with New Non-Executive Director AppointmentJune 5, 2025 | tipranks.comStephens & Co. Downgrades Blueprint Medicines (BPMC) to Equal Weight, Cuts PTJune 5, 2025 | insidermonkey.comCitizens JMP Downgrades Blueprint Medicines (BPMC) to Market PerformJune 5, 2025 | insidermonkey.comBeOne Medicines: Competitive Advantage Of Zanubrutinib In The CLL FieldJune 4, 2025 | seekingalpha.comWolfe Research Lowered Blueprint Medicines Corporation (BPMC) from Outperform to Peer PerformJune 3, 2025 | insidermonkey.com Get Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for MDCO and its competitors with MarketBeat's FREE daily newsletter. Email Address MDCO Media Mentions By Week MDCO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDCO News Sentiment▼0.001.01▲Average Medical News Sentiment MDCO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDCO Articles This Week▼95▲MDCO Articles Average Week Get Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for MDCO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RPRX News Today CORT News Today JAZZ News Today PRGO News Today SUPN News Today PCRX News Today NKTR News Today OMER News Today ASMB News Today CPIX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDCO) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Medicines Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDCO Stock Alerts